INR 32.41
(-7.37%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 8.41 Million | 4.77 Million | 3.86 Million | 4.8 Million | 5.1 Million |
Cost of Revenue | 3.32 Million | 1.87 Million | 690 Thousand | 690 Thousand | 830.7 Thousand |
Gross Profit | 5.09 Million | 2.9 Million | 3.17 Million | 4.11 Million | 4.27 Million |
Operating Expenses | 10.02 Million | -3.48 Million | 2.05 Million | 2 Million | 560.21 Thousand |
Selling, General and Administrative Expenses | 3.04 Million | 153.4 Thousand | 448.6 Thousand | 479.2 Thousand | 430.53 Thousand |
Research and Development Expenses | - | - | - | - | - |
Other Expenses | 6.98 Million | - | - | - | 129.67 Thousand |
Cost and Expenses | 13.34 Million | -1.61 Million | 2.74 Million | 2.69 Million | 560.21 Thousand |
Operating Income | -4.93 Million | 6.38 Million | 308.8 Thousand | 2.12 Million | -560.21 Thousand |
Interest Expense | - | - | - | - | - |
Income Tax Expense | -1.94 Million | 1.42 Million | 537.7 Thousand | 331.9 Thousand | 262.26 Thousand |
Earnings before Tax | -4.93 Million | 6.38 Million | 1.97 Million | 2.13 Million | 1.64 Million |
Net Income | -2.98 Million | 4.95 Million | 1.43 Million | 1.79 Million | 1.37 Million |
Earnings Per Share Basic | -0.70 | 1.17 | 0.34 | 0.42 | 0.32 |
Earnings Per Share Diluted | -0.70 | 1.17 | 0.34 | 0.42 | 0.32 |
Weighted Average Shares Outstanding | 4.26 Million | 4.23 Million | 4.24 Million | 4.24 Million | 4.24 Million |
Weighted Average Shares Outstanding (Diluted) | 4.26 Million | 4.23 Million | 4.24 Million | 4.24 Million | 4.24 Million |
Gross Margin | 0.61 | 0.61 | 0.82 | 0.86 | 0.84 |
EBIT Margin | -0.58 | 1.34 | 0.08 | 0.44 | -0.11 |
Profit Margin | -0.36 | 1.04 | 0.37 | 0.37 | 0.27 |
EBITDA | -4.91 Million | 6.39 Million | 319.8 Thousand | 2.13 Million | 1.65 Million |
Earnings Before Tax Margin | -0.59 | 1.34 | 0.08 | 0.44 | -0.11 |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Revenue | 724 Thousand | 5.03 Million | 8.41 Million | 1.77 Million | 574 Thousand | 1.02 Million |
Cost of Revenue | 1 Million | 975 Thousand | 3.32 Million | 747 Thousand | 819 Thousand | 782 Thousand |
Gross Profit | -282 Thousand | 4.06 Million | 5.09 Million | 1.03 Million | -245 Thousand | 240 Thousand |
Operating Expenses | -21.34 Million | 23.56 Million | 10.02 Million | -4.88 Million | -6.92 Million | -1.72 Million |
Selling, General and Administrative Expenses | 995 Thousand | 965 Thousand | - | 715 Thousand | 690 Thousand | 675 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | -21.34 Million | - | - | - | - | - |
Cost and Expenses | -20.34 Million | 24.53 Million | 13.34 Million | -4.13 Million | -6.1 Million | -947 Thousand |
Operating Income | 21.06 Million | -19.49 Million | -4.93 Million | 5.91 Million | 6.67 Million | 1.96 Million |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | 3.6 Million | -3.69 Million | -1.94 Million | -62 Thousand | 1.31 Million | 500 Thousand |
Earnings before Tax | 21.06 Million | -19.49 Million | -4.93 Million | 5.91 Million | 6.67 Million | 1.96 Million |
Net Income | 17.46 Million | -15.79 Million | -2.98 Million | 5.97 Million | 5.36 Million | 1.46 Million |
Earnings Per Share Basic | 4.11 | -3.72 | - | 1.41 | 1.26 | 0.32 |
Earnings Per Share Diluted | 4.11 | -3.72 | - | 1.41 | 1.26 | 0.32 |
Weighted Average Shares Outstanding | 4.24 Million | 4.24 Million | 4.26 Million | 4.23 Million | 4.25 Million | 4.59 Million |
Weighted Average Shares Outstanding (Diluted) | 4.24 Million | 4.24 Million | 4.26 Million | 4.23 Million | 4.25 Million | 4.59 Million |
Gross Margin | -0.39 | 0.81 | 0.61 | 0.58 | -0.43 | 0.23 |
EBIT Margin | 29.10 | -3.87 | - | 3.33 | 11.64 | 1.93 |
Profit Margin | 24.12 | -3.13 | -0.36 | 3.36 | 9.34 | 1.44 |
EBITDA | 21.07 Million | -19.48 Million | - | 5.91 Million | 6.68 Million | 1.97 Million |
Earnings Before Tax Margin | 29.10 | -3.87 | -0.59 | 3.32 | 11.63 | 1.93 |
002989
4848
BIOGEN
EGTYF
2119
CGLO